Showing results (3021-3030 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|September 24, 2020
A Pilot Study of Checkpoint Inhibitors in Solid Organ Transplant Recipients with Metastatic Cutaneous Squamous Cell CarcinomaIrene Tsung, Francis P Worden, Robert J Fontana
The Oncologist|September 1, 2020
Modified ypTNM Staging Classification for Gastric Cancer after Neoadjuvant Therapy: A Multi-Institutional StudyQing Zhong, Qi-Yue Chen, Amilcare Parisi, et al.
The Oncologist|March 11, 2020
The European Medicines Agency Review of Gilteritinib (Xospata) for the Treatment of Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia with an FLT3 MutationKyriaki Tzogani, Hilde Røshol, Helga Haugom Olsen, et al.
The Oncologist|March 13, 2020
Nivolumab for the Treatment of Patients with Metastatic Non-Clear Cell Renal Cell Carcinoma (nccRCC): A Single-Institutional Experience and Literature Meta-AnalysisJad Chahoud, Pavlos Msaouel, Matthew T Campbell, et al.
The Oncologist|March 13, 2020
Effect of a Skills Training for Oncologists and a Patient Communication Aid on Shared Decision Making About Palliative Systemic Treatment: A Randomized Clinical TrialInge Henselmans, Hanneke W M van Laarhoven, Pomme van Maarschalkerweerd, et al.
The Oncologist|March 13, 2020
Polypharmacy, Inappropriate Medication Use, and Drug Interactions in Older Korean Patients with Cancer Receiving First-Line Palliative ChemotherapySoojung Hong, Ju Hyun Lee, Eun Kyeong Chun, et al.
The Oncologist|March 13, 2020
From Somatic Variants Toward Precision Oncology: An Investigation of Reporting Practice for Next-Generation Sequencing-Based Circulating Tumor DNA AnalysisRongxue Peng, Rui Zhang, Martin P Horan, et al.
The Oncologist|March 13, 2020
Challenges and Opportunities to Updating Prescribing Information for Longstanding Oncology DrugsErin P Balogh, Andrew B Bindman, S Gail Eckhardt, et al.
The Oncologist|March 13, 2020
Prognostic and Predictive Value of Microsatellite Instability, Inflammatory Reaction and PD-L1 in Gastric Cancer Patients Treated with Either Adjuvant 5-FU/LV or Sequential FOLFIRI Followed by Cisplatin and Docetaxel: A Translational Analysis from the ITACA-S TrialMaria Di Bartolomeo, Federica Morano, Alessandra Raimondi, et al.
The Oncologist|March 13, 2020
Guardant360 Circulating Tumor DNA Assay Is Concordant with FoundationOne Next-Generation Sequencing in Detecting Actionable Driver Mutations in Anti-EGFR Naive Metastatic Colorectal CancerRohan Gupta, Tamer Othman, Chen Chen, et al.
Pageof 571